An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
Oxaprozin has been studied across 17 research domains including 🔬 Inflammation, 🦴 Bone & Joint, 💊 Pain, 🫁 Liver & Detox, 🦠 Gut & Microbiome. The primary research focus is 🔬 Inflammation with 75% of studies addressing this area.
The following compounds share molecular targets with Oxaprozin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Oxaprozin is generated deterministically from 181 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.